Back to Search
Start Over
Updated Study Results of CX-01, an Inhibitor of CXCL12/CXCR4, and Azacitidine for the Treatment of Hypomethylating Agent Refractory AML and MDS
- Source :
- Blood; November 2019, Vol. 134 Issue: 1, Number 1 Supplement 1 p3915-3915, 1p
- Publication Year :
- 2019
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 134
- Issue :
- 1, Number 1 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs56889577
- Full Text :
- https://doi.org/10.1182/blood-2019-132065